AAO 2024: Retinal Vascular Health Updates
During the 2024 AAO Annual Meeting, presenters discussed various posters and research on retinal vascular health.
Read More
Dissemination (Meeting Coverage)
ESMO 2024: Renal Cell Carcinoma Highlights
During the 2024 annual ESMO Congress, multiple poster sessions focused on the treatment of renal cell carcinoma (RCC).
Read More
Lung Function Continues to Decline in Uncontrolled Asthma With Treatment
Even after treatment with inhaled corticosteroids alone or in combination with long-acting antagonists, lung function decline continues in uncontrolled asthma.
Read More
Reducing Opioid Use in Acute Dental Pain Management Through Evidence-Based Alternatives
During the 106th AAOMS Annual Meeting, Scientific Session and Exhibition, various sessions covered acute dental pain while lowering opioid use among these patients.
Read More
Diagnosing & Managing Temporomandibular Joint Pain
The TMD Pain Screener was useful for ruling out whether tooth pain presenting in patients to endodontists had temporomandibular joint disorders.
Read More
Protein Glycosylation Predicts Resistance and Treatment Response in aRCC
Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.
Read More
Immunotherapy Beats Standard Care in Metastatic Non-Clear Cell Renal Cancer
The SUNNIFORECAST trial (LBA75), presented by Dr. Lothar Bergmann from Germany on Friday,...
Read More
Exploring Non-Opioid Post-Operative Pain Management Strategies for Third Molar Surgery
Researchers reviewed alternative and complementary therapies for postoperative pain management in patients undergoing lower third molar surgery.
Read More
AAOMS 2024 On-Demand Sessions
This years AAOMS annual meeting will include on-demand sessions that will be available starting on September 9, 2024.
Read More
Will You Be Playing AAOMSopoly Game?
Back by popular demand! Attendees are invited to join the fun by participating in AAOMSopoly, an exciting Exhibit Hall game available on the Annual Meeting mobile app.
Read More
CTNNB1 Alterations Affect Outcomes in Patients With HCC
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Read More
Why Do Physicians Order NSCLC Biomarker Tests, and Who Gets Appropriate Targeted Therapy?
Biomarker tests for non-small lung cancer (NSCLC) improve patient outcomes, but they are not available to everyone.
Read More
Targeted Sequencing Adds Value to FISH for Detecting Genetic Alterations in CLL
Researchers evaluated whether targeted next-generation sequencing was comparable to fluorescence in situ hybridization for detecting genetic alterations in CLL.
Read More
Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy
Adding BCR kinase inhibitor ibrutinib or idelalisib to monoclonal antibody pembrolizumab increases treatment efficacy in CLL with Richter transformation.
Read More
Molecular Testing Appears To Be Increasing in eNSCLC
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read More
Black Patients With HCC Less Likely to Receive Curative Treatment
Black patients with HCC are less likely than White patients to receive curative treatment.
Read More
High-Dose Melphalan Conditioning Benefits Patients With Multiple Myeloma
High-dose melphalan conditioning confers survival benefits in patients with extramedullary and non-extramedullary multiple myeloma.
Read More
Targeted Interventions Benefit African Americans With Multiple Myeloma
African Americans benefit from targeted multiple myeloma interventions.
Read More
AI’s Increasing Capacity to Outperform Human Detection of Lung Cancer
AI detects lung cancer better than humans do.
Read More
Understanding the Needs of Patients With Hepatocellular Carcinoma & Their Caregivers
While patients with hepatocellular carcinoma largely felt independent, their caregivers reported burdens related to appointment logistics and emotional support.
Read More